Clinical trial
Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast…
NCT00193778 · Tata Memorial Hospital, Other · Completed
Key facts
| NCT number | NCT00193778 |
|---|---|
| Title | Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation |
| Official title | A Randomized Trial To Assess The Impact Of Loco-Regional Treatment On Survival Of Patients With Metastatic Breast Cancer At First Presentation |
| Lead sponsor | Tata Memorial Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cancer of the Breast |
| Intervention type | Other, Procedure |
| Interventions | Surgery for breast cancer, No Loco-regional treatment |
| Enrollment | 350 |
| Start date | Feb 1, 2005 |
| Primary completion | Jul 30, 2020 |
| Completion | Jul 30, 2020 |
| First posted | Sep 19, 2005 |
| Last update posted | Oct 8, 2020 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: